MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

Don’t worry, it’s not just you. Everyone dropped their first, or likely fortieth, F-bomb when their dad had them hold the spark plug while he hit the kickstarter on their dirt bike. While it might ...

When people come together and talk about really interesting topics, great questions spark better understanding and opportunities for new ideas to form. On The Spark from WITF, host Asia Tabb starts ...

Abstract: As a kind of deep-sea exploration equipment, deep-sea submersible can fundamentally satisfy the deep-sea exploration mission, and it is the commanding point of marine technology development.

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...